Treating advanced hepatocellular carcinoma: How to get out of first gear

Publisher： John Wiley & Sons Inc

E-ISSN： 1097-0142|120|20|3122-3130

ISSN： 0008-543x

Source： CANCER, Vol.120, Iss.20, 2014-10, pp. : 3122-3130

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Laparoscopic liver resection for treating recurrent hepatocellular carcinoma

By  

JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, Vol. 20, Iss. 5, 2013-06 ,pp. : 512-517

John Wiley & Sons Inc

Access to resources Recommend Favorite

Efficacy and Tolerability of Low-Dose Thalidomide as First-Line Systemic Treatment of Patients with Advanced Hepatocellular Carcinoma

By  

Oncology, Vol. 72, Iss. 1, 2007-12 ,pp. : 67-71

Karger

Access to resources Recommend Favorite

Bevacizumab with Erlotinib as First-line Therapy in Asian Patients with Advanced Hepatocellular Carcinoma: A Multicenter Phase II Study

By  

Oncology, Vol. 85, Iss. 1, 2013-07 ,pp. : 44-52

Karger

Access to resources Recommend Favorite

How to get the most out of your GP tutorials

By Baishnab Elora  

InnovAiT, Vol. 5, Iss. 9, 2012-09 ,pp. : 561-566

Oxford University Press

Access to resources Recommend Favorite

Low-Dose Thalidomide Treatment for Advanced Hepatocellular Carcinoma

By  

Oncology, Vol. 65, Iss. 3, 2003-12 ,pp. : 242-249

Karger

Access to resources Recommend Favorite